Acquiring Company
GBL SA
Acquired Company
Recordati
Description
GBL SA is set to acquire Recordati using the Respighi BidCo vehicle, a special-purpose entity promoted by CVC Capital Partners Fund IX along with GBL. This takeover marks a strategic move for GBL to expand its influence in the pharmaceutical sector. The acquisition is part of GBL's broader investment strategy for long-term growth and value creation.
Don't miss GBL SA's next move
Get an email the moment GBL SA makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
M&A Insights
Based on deal dataFrequently asked
Who acquired Recordati?
Recordati was acquired by GBL SA, based in Belgium. The deal was reported on August 29, 2026. GBL SA is a diversified investment company. It manages a portfolio of international investments and provides strategic direction to its holdings. GBL SA is privately held and operates in Health Care.
When did GBL SA acquire Recordati?
GBL SA's acquisition of Recordati was reported on August 29, 2026. GBL SA is set to acquire Recordati using the Respighi BidCo vehicle, a special-purpose entity promoted by CVC Capital Partners Fund IX along with GBL. This takeover marks a strategic move for GBL to expand its influence in the pharmaceutical sector. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Recordati do?
Recordati is a leading Italian pharmaceutical group focused on research, development, and marketing of pharmaceuticals. The company is committed to enriching and prolonging the lives of people all over the world through its innovative pharmaceutical products. It is privately held, operating in Manufacturing, and is based in Milan.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.